Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Operating Expenses: 2020-2025

Historic Operating Expenses for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$15,057.

  • Molecular Partners Ag's Operating Expenses rose 14.57% to -$15,057 in Q3 2025 from the same period last year, while for Sep 2025 it was $54.7 million, marking a year-over-year decrease of 4.87%. This contributed to the annual value of $75.2 million for FY2024, which is 0.85% down from last year.
  • Molecular Partners Ag's Operating Expenses amounted to -$15,057 in Q3 2025, which was up 99.93% from -$20.9 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Operating Expenses ranged from a high of $76.9 million in Q4 2023 and a low of -$43.0 million during Q2 2021.
  • In the last 3 years, Molecular Partners Ag's Operating Expenses had a median value of -$18,148 in 2023 and averaged $8.5 million.
  • Per our database at Business Quant, Molecular Partners Ag's Operating Expenses skyrocketed by 298.23% in 2022 and then crashed by 96,613.37% in 2023.
  • Molecular Partners Ag's Operating Expenses (Quarterly) stood at $19.0 million in 2021, then skyrocketed by 298.23% to $75.8 million in 2022, then increased by 1.40% to $76.9 million in 2023, then decreased by 1.65% to $75.6 million in 2024, then climbed by 14.57% to -$15,057 in 2025.
  • Its Operating Expenses was -$15,057 in Q3 2025, compared to -$20.9 million in Q2 2025 and -$17,954 in Q1 2025.